• About Us
    • Company Overview
    • Our History
    • Leadership
    • Board of Directors
    • Our Advisors
  • Therapeutic Areas
    • COVID-19 and CVD
    • Acute Myocarditis
    • Heart Failure
  • Research
    • R&D Partners
    • Our Science
    • Resources
  • Pipeline
  • CardiolRX™
  • Investors
    • Events & Presentations
    • Press Releases
    • Analyst Coverage
    • Stock Information
    • Filings & Financials
    • Corporate Governance
    • Contact Us
News

Cardiol Therapeutics Submits Application for Uplisting to the Nasdaq and Raises Proceeds of Over $10 Million from Exercise of Warrants and Options

March 02, 2021

Cardiol Therapeutics Announces Formation of Data Safety Monitoring and Clinical Endpoint Committees for Phase II/III Outcomes Trial in High-Risk Patients Hospitalized with COVID-19

January 21, 2021

Cardiol Therapeutics to Participate in Upcoming Virtual Investor Conferences

January 07, 2021

Cardiol Therapeutics Announces Completion of Phase I Clinical Study of CardiolRx™

December 22, 2020

Cardiol Therapeutics Appoints Worldwide Clinical Trials as CRO for the Company’s Phase II/III Outcomes Trial in High-risk Patients Hospitalized with COVID-19

December 15, 2020

Cardiol Therapeutics’ Cortalex™ CBD Now Available Exclusively Online at Medical Cannabis by Shoppers Inc.

October 20, 2020

Cardiol Therapeutics Receives FDA Approval for Investigational New Drug (IND) Application for Phase II/III COVID-19 Trial

September 25, 2020

Cardiol Therapeutics to Present at the H.C. Wainwright Virtual 22nd Annual Global Investment Conference

September 15, 2020

Cardiol Therapeutics Initiates Health Canada Approved Phase 1 Clinical Study of CardiolRx™

August 26, 2020

Cardiol Therapeutics Appoints CNBC Market Analyst Steven Grasso as Business Advisor

June 29, 2020
Page 1 of 712345...»Last »
  • About Us
  • Therapeutic Areas
  • Research
  • Pipeline
  • CardiolRX™
  • Investors
  • Contact

TSX:CRDL OTCQX:CRTPF FSE:CT9

Sign up to receive the latest news from Cardiol Therapeutics

© 2021 Cardiol Therapeutics Inc. All rights reserved.      Terms of Use      Privacy Policy